These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 38640869)
1. Identification of a new bisindolinone arresting IGROV1 cells proliferation. Morigi R; Zalambani C; Farruggia G; Verardi L; Esposito D; Leoni A; Borsetti F; Voltattorni M; Zambonin L; Pincigher L; Calonghi N; Locatelli A Eur J Med Chem; 2024 May; 271():116365. PubMed ID: 38640869 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and Biological Evaluation of New Bis-Indolinone Derivatives Endowed with Cytotoxic Activity. Morigi R; Catanzaro E; Locatelli A; Calcabrini C; Pellicioni V; Leoni A; Fimognari C Molecules; 2021 Oct; 26(20):. PubMed ID: 34684858 [TBL] [Abstract][Full Text] [Related]
3. Indirubin Derivatives as Dual Inhibitors Targeting Cyclin-Dependent Kinase and Histone Deacetylase for Treating Cancer. Cao Z; Yang F; Wang J; Gu Z; Lin S; Wang P; An J; Liu T; Li Y; Li Y; Lin H; Zhao Y; He B J Med Chem; 2021 Oct; 64(20):15280-15296. PubMed ID: 34624191 [TBL] [Abstract][Full Text] [Related]
4. Novel indole hydrazide derivatives: Synthesis and their antiproliferative activities through inducing apoptosis and DNA damage. Kilic-Kurt Z; Acar C; Ergul M; Bakar-Ates F; Altuntas TG Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000059. PubMed ID: 32419228 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of novel indole-thiazolidinone hybrid structures as promising scaffold with anticancer potential. Kryshchyshyn-Dylevych A; Radko L; Finiuk N; Garazd M; Kashchak N; Posyniak A; Niemczuk K; Stoika R; Lesyk R Bioorg Med Chem; 2021 Nov; 50():116453. PubMed ID: 34634616 [TBL] [Abstract][Full Text] [Related]
6. Substituted E-3-(3-indolylmethylene)1,3-dihydroindol-2-ones with antiproliferative activity. Study of the effects on HL-60 leukemia cells. Leoni A; Locatelli A; Morigi R; Rambaldi M; Cappadone C; Farruggia G; Iotti S; Merolle L; Zini M; Stefanelli C Eur J Med Chem; 2014 May; 79():382-90. PubMed ID: 24747749 [TBL] [Abstract][Full Text] [Related]
7. Oxidative trimerization of indoles via water-assisted visible-light photoredox catalysis and the study of their anti-cancer activities. Cheng LT; Luo SQ; Hong BC; Chen CL; Li WS; Lee GH Org Biomol Chem; 2020 Aug; 18(32):6247-6252. PubMed ID: 32735638 [TBL] [Abstract][Full Text] [Related]
8. 3-Arylidene-N-hydroxyoxindoles: A New Class of Compounds Endowed with Antitumor Activity. Musso L; Cincinelli R; Zuco V; De Cesare M; Zunino F; Fallacara AL; Botta M; Dallavalle S ChemMedChem; 2016 Aug; 11(16):1700-4. PubMed ID: 27311681 [TBL] [Abstract][Full Text] [Related]
9. Discovery of pyrrolospirooxindole derivatives as novel cyclin dependent kinase 4 (CDK4) inhibitors by catalyst-free, green approach. Kamal A; Mahesh R; Nayak VL; Babu KS; Kumar GB; Shaik AB; Kapure JS; Alarifi A Eur J Med Chem; 2016 Jan; 108():476-485. PubMed ID: 26708114 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of 2-indolinone derivatives as potential antitumor agents. Zou H; Zhang L; Ouyang J; Giulianotti MA; Yu Y Eur J Med Chem; 2011 Dec; 46(12):5970-7. PubMed ID: 22019188 [TBL] [Abstract][Full Text] [Related]
11. "On water" expedient synthesis of 3-indolyl-3-hydroxy oxindole derivatives and their anticancer activity in vitro. Sai Prathima P; Rajesh P; Venkateswara Rao J; Sai Kailash U; Sridhar B; Mohan Rao M Eur J Med Chem; 2014 Sep; 84():155-9. PubMed ID: 25016373 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and evaluation of novel indirubin-based N-hydroxybenzamides, N-hydroxypropenamides and N-hydroxyheptanamides as histone deacetylase inhibitors and antitumor agents. Anh DT; Hai PT; Dung DTM; Dung PTP; Huong LT; Park EJ; Jun HW; Kang JS; Kwon JH; Tung TT; Han SB; Nam NH Bioorg Med Chem Lett; 2020 Nov; 30(22):127537. PubMed ID: 32916298 [TBL] [Abstract][Full Text] [Related]
13. New Isatin-Indole Conjugates: Synthesis, Characterization, and a Plausible Mechanism of Their in vitro Antiproliferative Activity. Al-Wabli RI; Almomen AA; Almutairi MS; Keeton AB; Piazza GA; Attia MI Drug Des Devel Ther; 2020; 14():483-495. PubMed ID: 32099332 [TBL] [Abstract][Full Text] [Related]
14. Unconventional Knoevenagel-type indoles: Synthesis and cell-based studies for the identification of pro-apoptotic agents. Spallarossa A; Caneva C; Caviglia M; Alfei S; Butini S; Campiani G; Gemma S; Brindisi M; Zisterer DM; Bright SA; Williams CD; Crespan E; Maga G; Sanna G; Delogu I; Collu G; Loddo R Eur J Med Chem; 2015 Sep; 102():648-60. PubMed ID: 26320088 [TBL] [Abstract][Full Text] [Related]
15. Discovery of bazedoxifene analogues targeting glycoprotein 130. Song D; Yu W; Ren Y; Zhu J; Wan C; Cai G; Guo J; Zhang W; Kong L Eur J Med Chem; 2020 Aug; 199():112375. PubMed ID: 32388278 [TBL] [Abstract][Full Text] [Related]
16. Gold-containing indoles as anticancer agents that potentiate the cytotoxic effects of ionizing radiation. Craig S; Gao L; Lee I; Gray T; Berdis AJ J Med Chem; 2012 Mar; 55(5):2437-51. PubMed ID: 22289037 [TBL] [Abstract][Full Text] [Related]
17. Facile synthesis of simple 2-oxindole-based compounds with promising antiproliferative activity. George RF Future Med Chem; 2018 Feb; 10(3):269-282. PubMed ID: 29334243 [TBL] [Abstract][Full Text] [Related]
18. H2O-mediated isatin spiro-epoxide ring opening with NaCN: Synthesis of novel 3-tetrazolylmethyl-3-hydroxy-oxindole hybrids and their anticancer evaluation. Sharma P; Senwar KR; Jeengar MK; Reddy TS; Naidu VG; Kamal A; Shankaraiah N Eur J Med Chem; 2015 Nov; 104():11-24. PubMed ID: 26413726 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, biological evaluation and structure-activity relationship of sophoridine derivatives bearing pyrrole or indole scaffold as potential antitumor agents. Li Z; Luo M; Cai B; Haroon-Ur-Rashid ; Huang M; Jiang J; Wang L; Wu L Eur J Med Chem; 2018 Sep; 157():665-682. PubMed ID: 30125725 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of novel 7-azaindazolyl-indolyl-maleimide derivatives as antitumor agents and protein kinase C inhibitors. Ye Q; Cao J; Zhou X; Lv D; He Q; Yang B; Hu Y Bioorg Med Chem; 2009 Jul; 17(13):4763-72. PubMed ID: 19447039 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]